Hedgehog (Hh) signaling modulates T cell development and function but its exact role remains a matter of debate. To further address this issue we made use of conditional knock-out mice in which the Hh receptor Patched1 (Ptch) is inactivated in the T cell lineage. Thymocyte development was moderately compromised by the deletion of Ptch as characterized by reduced numbers of CD4 and CD8 single-positive cells. In contrast, peripheral T cells were not affected. Proliferation and IFNγ secretion by Ptch-deficient T cells were indistinguishable from controls irrespectively of whether we used strong or suboptimal conditions for stimulation. Analysis of CTL and Treg cell functions did not reveal any differences between both genotypes, and T cell apoptosis induced by glucocorticoids or γ-irradiation was also similar. Surprisingly, absence of Ptch did not lead to an activation of canonic Hh signaling in peripheral T cells as indicated by unaltered expression levels of Gli1 and Gli2. To test whether we could uncover any role of Ptch in T cells in vivo we subjected the mutant mice to three different disease models, namely allogeneic bone marrow transplantation mimicking graft-versus-host disease, allergic airway inflammation as a model of asthma and growth of adoptively transferred melanoma cells as a means to test tumor surveillance by the immune system. Nonetheless, we were neither able to demonstrate any difference in the disease courses nor in any pathogenic parameter in these three models of adaptive immunity. We therefore conclude that the Hh receptor Ptch is dispensable for T cell function in vitro as well as in vivo.
Citation: Michel KD, Uhmann A, Dressel R, van den Brandt J, Hahn H, Reichardt HM (2013) The Hedgehog Receptor Patched1 in T Cells Is Dispensable for Adaptive Immunity in Mice. PLoS ONE 8(4): e61034. https://doi.org/10.1371/journal.pone.0061034
Editor: Andreas Villunger, Innsbruck Medical University, Austria
Received: December 23, 2012; Accepted: March 5, 2013; Published: April 8, 2013
Copyright: © 2013 Michel et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grants from the Deutsche Forschungsgemeinschaft (RE1631/8-1 and HA2197/6-1) and Deutsche Krebshilfe (108713). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
The Hh signaling pathway plays a critical role in development, cell fate decisions and tissue growth. Ptch, the receptor for Hh, inhibits its signaling partner Smoothened (Smo). Binding of Hh to Ptch or inactivating Ptch mutations result in derepression of Smo. This in turn triggers a cascade of downstream events which culminate in the activation of the Gli transcription factors Gli2 and Gli3, eventually leading to the expression of Hh target genes. Those include Gli1, which further amplifies the initial Hh signal at the transcriptional level, and frequently Ptch itself , .
Several members of the Hh signaling pathway such as Smo, Ptch and Gli1 are expressed in T cells , . As a matter of fact, various experimental studies indicated that Hh signaling plays a crucial role in T cell development. For example, Sonic Hedgehog (Shh), the main mediator of Hh signaling, regulates differentiation from double-negative to double-positive thymocyte and controls thymocyte progenitor homeostasis , , . In the thymus, cell-intrinsic Gli2 levels modulate the ratio of CD4 to CD8 single-positive cells , and stromal Gli3 expression was proposed to be involved in the differentiation of T cells . In addition, we and others have identified Ptch as an exclusively T cell-extrinsic factor necessary for proper development of T cells at their prethymic stage , , .
Besides its involvement in T cell development, Hh signaling may also control the function of mature T lymphocytes. Analysis of peripheral T cells revealed that activation of CD4+ or CD8+ T cells with anti-CD3/CD28 antibodies increased the expression of Smo . Addition of recombinant Shh-N enhanced the proliferative capacity of T cells, in particular under suboptimal conditions , , . It also increased production of cytokines such as IL-2, IL-4, TNFα and IFNγ elicited by the treatment with anti-CD3 antibodies and led to an upregulation of activation markers such as CD25 and CD69 , . Shh-N cooperated with anti-CD3 antibodies in enhancing cyclin A and cytokine-inducible SH2-containing protein (CIS-1) expression, thus mimicking T cell receptor costimulation . In contrast, Shh-N did not augment Bcl-XL levels in anti-CD3 stimulated CD4+ T cells, indicating that Hh and CD28 signaling share some but not all downstream targets . A possible explanation for the impact of Hh signaling on T cell proliferation came from the finding that Bcl-2 is upregulated by addition of Shh during T cell activation .
On the other hand, several data argue for a repressive rather than an activating function of Hh signaling in T lymphocytes. Inhibition of the Hh pathway by transgenic overexpression of the repressor form of Gli2 under the lck promoter (Gli2ΔC2) increased differentiation from double- into single-positive thymocytes and augmented peripheral T cell numbers . The Gli2ΔC2 transgene also conferred hyper-responsiveness when T cells were activated by ligation with anti-CD3 and anti-CD28 antibodies . Vice versa, constitutive activation of Hh signaling by expression of a transgenic activator form of Gli2 under the control of the lck promoter (Gli2ΔN2) inhibited T cell activation and proliferation, probably by repressing TCR signal transduction . Finally, one study in which Smo was conditionally deleted from T cells failed to reveal any influence of the loss of Hh signaling on anti-CD3 induced T cell proliferation . This highlights that the currently available data regarding the role of Hh signaling in T cells are highly contradictory.
We recently reported that thymocyte development was independent of T cell-intrinsic Ptch expression . Using a pure C57BL/6 background we here reinvestigated the role of Ptch in T cell development and additionally analyzed its function in peripheral T cells. This was accomplished by conditionally ablating Ptch by breeding Ptchflox/flox mice with CD4Cre transgenic mice, by analyzing thymocytes and various subsets of peripheral T lymphocytes in vitro and by subjecting the mutant mice to three different models of adaptive immune responses in vivo. However, despite a comprehensive set of assays addressing many different aspects of T cell function we were unable to identify any role of Ptch in this cell type. Our findings therefore argue that the Hh receptor Ptch, although not necessarily Hh signaling itself, does not play a major role in peripheral T cells.
Materials and Methods
All mice were bred under SPF conditions in our animal facility in Göttingen and used at an age of 6–24 weeks. Food and drinking water were provided ad libitum. Ptchflox/flox CD4Cre+/− mice were obtained by crossing Ptchflox/flox mice  with CD4Cre+/− transgenic mice , which results in the recombination of the Ptchflox locus starting at the DN3 stage of thymocyte development . Importantly, a T cell-specific phenotype has neither been reported for CD4Cre+/− transgenic nor Ptchflox/flox mice, which allowed us to use them as controls in our experiments , , . For most in vitro and all in vivo experiments mice had been backcrossed to the C57BL/6 background for more than 10 generations. Genotyping was achieved by PCR using the previously described primer combinations . C3H/HeN, C57BL/6 and Balb/c mice were purchased from Charles River (Sulzfeld, Germany). All animal experiments were conducted according to ethical standards of humane animal care and approved by the authorities of Lower Saxony (Nds. Landesamt für Verbraucherschutz und Lebensmittelsicherheit, Permit Numbers: 33.9.42502-04/007/08; 33.9.42502-04/049/08; 33.14.42502-04/109/09). All efforts were made to minimize suffering of the mice.
Thymocytes and splenocytes were obtained by mechanical breakup of freshly dissected organs using forceps before the cells were passed through a 40 µm nylon mesh and washed in phosphate-buffered saline (PBS) plus 0.1% BSA. Alternatively, cells were directly used after magnetic separation or cell culture. All antibodies for FACS staining were obtained from BD Biosciences (Heidelberg, Germany), BioLegend (Uithoorn, The Netherlands), eBiosciences (Frankfurt, Germany) or AbD Serotech (Düsseldorf, Germany) and directed against the following antigens (clone name in parenthesis): TCRβ (H57-597), CD3ε (17A2), CD4 (RM4-5), CD8α (53-6.7), CD25 (7D4), CD44 (IM7), CD69 (H1-2F3), GITR (DTA-1), FoxP3 (FJK-16s), F4/80 (CI:A3-1), Ly-6C/G (Gr-1; RB6-8C5) and SiglecF (E50-2440). 7-AAD was purchased from BD Biosciences. The antibodies were either directly labeled with FITC, PE, PerCP, PE-Cy7, APC or APC-Cy7 or coupled to biotin, which was detected using a streptavidin-fluorochrome conjugate. Staining was performed according to standard procedures  and analyzed using a FACS Canto II device in combination with FACSDiva (BD Biosciences) or FlowJo (Treestar, Ashland/OR, USA) software. Intracellular staining of FoxP3 was accomplished using the Foxp3/Transcription Factor Staining Buffer Set according to the manufacturer’s instructions (eBioscience).
T cell Purification
T cells were magnetically isolated from total splenocytes as previously described  by using the Pan T Cell Isolation Kit II in conjunction with an autoMACS separator (both from Miltenyi Biotech, Bergisch Gladbach, Germany). Cell purity was assessed by FACS analysis and was routinely around 95%. CD4+CD25+ Treg cells and CD4+CD25− Th cells used for suppression assays were purified by employing the Regulatory T Cell Isolation Kit together with an autoMACS separator as described elsewhere . Cell purity was determined by FACS analysis using antibodies against TCRβ, CD4, GITR and FoxP3 and was routinely greater than 95%.
RNA Isolation and Quantitative RT-PCR
Total RNA was isolated from purified splenic T cells using the Quick-RNA Mini Prep Kit (Zymo Research, Irvine, CA, USA) or from mouse embryos using TRIZOL reagent (Invitrogen, Carlsbad, CA, USA). Reverse transcription was achieved with the help of the iScript cDNA Synthesis Kit (Bio-Rad, München, Germany) according to the manufacturers’ instructions. For relative quantification of gene expression, qRT-PCR was performed using the 7500 Real Time PCR System in conjunction with the Power SYBR Green PCR Master Mix (both from Applied Biosystems). Detection of individual transcripts was achieved using the following primer combinations: wt Ptch (5′- AAA GCC GAA GTT GGC CAT GGG TAC -3′/5′- TGC TTG GGA GTC ATT AAC TGG A -3′), Ptchdel (5′- AAA GCC GAA GTT GGC CAT GGG TAC -3′/5′- TTA AAC AGG CAT AGG CAA GCT GAC -3′), Ptch2 (5′- TCC AAG TAT CAC TCT ATG GGA AAT C -3′/5′- TTC TCA ATC ATC CGC TCG AT -3′), Gli1 (5′- TAC ATG CTG GTG GTG CAC ATG -3′/5′- ACC GAA GGT GCG TCT TGA GG -3′), Gli2 (5′- GGT CAT CTA CGA GAC CAA CTG C -3′/5′- GTG TCT TCA GGT TCT CCA GGC -3′). Amplification of HPRT1 (5′- GTC CTG TGG CCA TCT GCC TA -3′/5′ -GGG ACG CAG CAA CTG ACA TT -3′) served to normalize for the amount of cDNA in each sample. All samples were measured in duplicates and analyzed using the Sequence detection Software (Applied Biosystems).
Apoptosis of splenic T cells was induced by treatment with dexamethasone (Dex) or exposure to γ-irradiation. In brief, 2×105 cells were seeded in 96-well flat bottom plates and water-soluble Dex (Sigma-Aldrich, Taufkirchen, Germany) was added at escalating doses to the cultures. Alternatively, cells were exposed to different doses of γ-irradiation before culture using a RS 225 X-Ray Research System (Gulmay Medical Systems, Chertsey, Surrey, UK) operated at 150 kV, 15 mA and with a 0.5 mm Cu filtration. After 24–96 hours, cells were harvested, stained with 7-AAD and the amount of viable cells was determined by FACS analysis.
T Cell Activation and Proliferation Assay
For polyclonal T cell activation, 105 purified T lymphocytes were plated in 96-well flat bottom plates and stimulated for 24–72 hours either by adding ConA (Sigma-Aldrich) or soluble anti-CD3 and anti-CD28 antibodies (BD Biosciences or Biolegend) in suboptimal (0.5 µg/ml and 0.01 µg/ml, respectively) or optimal (2.5 µg/ml and 1.0 µg/ml, respectively) concentrations. Cells were stimulated in 200 µl RPMI 1640 medium with Glutamax, 10% fetal calf serum (FCS), 100 U/ml penicillin and 100 µg/ml streptomycin (all from Invitrogen, Karlsruhe, Germany). For quantification of IFNγ levels, an 50 µl aliquot of the supernatant was collected from each well and analyzed by ELISA using the BD OptEIA mouse IFNγ ELISA Set (BD Biosciences) according to the manufacturers’ instructions. For quantification of T cell proliferation, the cells were subsequently labeled with 3H-thymidine (Hartmann Analytics, Braunschweig, Germany) at a dose of 37 kBq/well and cultured for another 16 hours. The labeled DNA was collected onto Filtermat A glassfibre filters using a MicroBeta Filtermate-96 Harvester and encapsulated by MeltiLex solid scintillator. Quantification of the incorporated radioactivity was achieved using a MicroBeta2 ß-scintillation counter (all Perkin Elmer, Rodgau, Germany).
The suppressive capacity of Treg cells was determined essentially as described . Conventional CD4+CD25− Th cells (105 cells/well) were cultured in RPMI 1640 medium with Glutamax supplemented with 10% FCS and antibiotics in 96-well U-bottom plates with different ratios of syngeneic CD4+CD25+ Treg cells. Both cell types were either purified from Ptchflox/flox or Ptchflox/flox CD4Cre+/− mice. Polyclonal activation was achieved by adding 1 µg/ml soluble anti-CD3 and 5 µg/ml anti-CD28 antibodies into the cultures. Th or Treg cells alone (stimulated with anti-CD3 and anti-CD28) or unstimulated Th cells served as positive and negative controls. After 48 hours, supernatants were collected and IL-2 levels were assessed by using the BD OptEIA mouse IL-2 ELISA Set (BD Biosciences) according to the manufacturers’ instructions.
Alloreactive CTLs were generated by intraperitoneal immunization of Ptchflox/flox and Ptchflox/flox CD4Cre+/− mice (H2b) with 2×107 splenocytes obtained from C3H/HeN (H2k) mice. The immunization was repeated twice with an interval of 10 days. Another 10 days later the splenocytes were harvested and restimulated in vitro for 5 days by co-culturing 7.5×105 responder cells with 7.5×105 irradiated (25 Gy) splenocytes from C3H/HeN (H2k) mice. Coculture was done in 96-well U-bottom plates in 200 µl of NaHCO3-buffered Dulbecco’s modified Eagle’s medium (DMEM, Biochrom, Berlin, Germany), supplemented with 10% FCS (Biochrom), 1 mM sodium pyruvate, 2 mM L-glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin, 50 µM 2-mercaptoethanol (all from Sigma-Aldrich), 20 ng/ml recombinant mouse IL-2 (Immunotools, Friesoythe, Germany) and 50 µl of supernatant from ConA-stimulated rat lymphocytes. Mouse fibroblast Ltk− cells (H2k) were used as target cells for the alloreactive CTLs in 51chromium release assays, which were performed as described previously .
Measurement of Ig Serum Levels by ELISA
MaxiSorp flat bottom 96-well plates (Nunc GmbH, Langenselbold, Germany) were coated over night at 4°C with 50 µg/ml ovalbumin (Ova) in coating buffer (0.1 M sodium carbonate, pH = 9.5). The wells were washed with 0.05% Tween-20 in PBS and blocked with 10% FCS in PBS for 1 hour at room temperature. Subsequently, serum samples were added over night at 4°C. For IgE detection, the serum was initially incubated with Protein G PLUS agarose (Santa Cruz Biotechnology, Santa Cruz, CA, USA) to remove IgG antibodies, centrifuged and only the IgG-free supernatant was used. Ova-specific immunoglobulins were detected using HRP-coupled anti-IgG1, anti-IgG2a and anti-IgE specific antibodies (Southern Biotech, Birmingham, AL, USA). The reaction was quantified by measuring the absorbance at 450 nM and 570 nm using a PowerWave 340 ELISA reader (BioTek, Winooski, VT, USA).
Fixed tissue samples were dehydrated, embedded in paraffin and cut into 5 µm slices. The sections were mounted onto slides and stained with hematoxylin and eosin (Merck, Darmstadt, Germany) according to standard protocols. From each mouse lung, several sections were taken from central and peripheral regions and microphotography was performed using an Olympus BX51 microscope with an Olympus ColorView Camera operated by analySISB software.
Graft-versus-host Disease (GvHD) Mouse Model
To induce an acute GvHD reaction, 8–10 weeks old male Balb/c recipient mice received 107 T cell-depleted syngeneic bone marrow cells plus 2×106 T cells from Ptchflox/flox CD4Cre+/− or Ptchflox/flox control donor mice one day after irradiation with 8.5 Gy. In detail, bone marrow was isolated from femurs of C57Bl/6 mice and T cell depletion was achieved using anti-CD90.2 microbeads and an autoMACS separator (both from Miltenyi Biotech) according to the manufacturer’s instructions. Cell purity was assessed by FACS and revealed that T cell contamination was routinely less than 1%. T cells were isolated from spleens and cervical, mesenteric and inguinal lymph nodes of Ptchflox/flox CD4Cre+/− and Ptchflox/flox control C57BL/6 mice as described before . Bone marrow with or without (control) T cells was mixed and injected in a total volume of 200 µl PBS into the tail vein. Starting from one day before cell transfer, mice were kept on antibiotic water (25 µg/ml neomycin) for four weeks. Mice were monitored every other day for survival and their health status was assessed according to five clinical parameters (posture, activity, fur ruffling, diarrhea and weight loss) as described , each of which received a score from 0 to 2, resulting in a total score between 0 and 10. Due to ethical reasons, mice were sacrificed when the total clinical score exceeded a value of 7 for more than one day.
Allergic Airway Inflammation Mouse Model
Female Ptchflox/flox and Ptchflox/flox CD4Cre+/− mice were immunized on days 0, 9 and 18 by intraperitoneal injections of 10 µg chicken egg ovalbumin (Ova grade V; Sigma-Aldrich) together with 1.5 mg of aluminum hydroxide (Alhydrogel 2%, Invivogen, San Diego, Ca, USA) as the adjuvant in a total volume of 150 µl PBS. Control mice received intraperitoneal injections without Ova. From days 28 to 30, both immunized and control mice were challenged by daily intranasal administration of 150 µg Ova solubilized in PBS. Analysis was performed on day 32 after the initial immunization. To this end, mice were sacrificed by CO2 inhalation and a midline neck incision was made to cannulate the trachea. Lungs were rinsed with 500 µl PBS and the recovered BALF cell suspension was centrifuged, counted with a Neubauer counting chamber and used for FACS analysis. Eosinophils were distinguished from neutrophils and macrophages based on the combined staining for Siglec-F, F4/80 and Gr-1 (details are available upon request). Lungs were incubated at room temperature in Roti-Histofix 4% (Carl Roth GmbH, Karlsruhe, Germany) over night before they were used for histological analysis. For serum analysis, blood was collected from the vena renalis and centrifuged; the serum was then collected and frozen for later analysis. Splenocytes were isolated as described above and erythrocytes were lysed using a haemolysis buffer (400 µM Tris, 155 mM ammonium chloride, pH = 7.2). The cells were plated in 96-well flat bottom plates and stimulated with 10 µg/ml Ova for 72 hours. Non-stimulated or ConA-stimulated cells served as controls. Proliferation and cytokine production were assessed as described above.
Melanoma Mouse Model
The previously published B16-F10 murine melanoma cells were kindly provided by Dr. Jürgen Becker (Clinic of Dermatology, University of Würzburg, Germany) . The cells were grown in RPMI 1640 supplemented with 10% FCS, 100 U/ml penicillin and 100 µg/ml streptomycin. For tumor vaccination, cells were harvested, washed twice in PBS, irradiated with 125 Gy and mixed at a ratio of two volumes of cells to one volume of complete Freund’s adjuvant (CFA; Sigma-Aldrich). Subsequently, 106 cells were injected in a total volume of 150 µl subcutaneously into the left flank. Ten days after immunisation, mice were challenged with 104 live B16-F10 cells into the right flank. Starting from day 7 after challenge, mice were regularly monitored for palpable tumors. Tumor size was recorded from two caliper measurements of the longest (a) and shortest (b) diameter and the tumor volume was calculated according to the following formula: volume = a×b2×0.4 . The experiment was terminated for individual mice when the tumor volume exceeded 800 mm3 or when ulceration or bleeding occurred.
Disruption of Ptch in the T Cell Lineage Moderately Impacts Thymocyte Development while Peripheral T Lymphocytes are Unaffected
We previously reported that T cell-specific deletion of Ptch did not impact thymocyte development in Ptchflox/flox CD4Cre+/− mice . As our findings were in contrast to several other reports describing an influence of Hh signaling on the transition from the double-positive (DP) to the single-positive (SP) stage of thymocyte development , , , we decided to repeat the analyses with mice backcrossed to the C57BL/6 background. Although the overall thymic cellularity (Figure 1A) and the percentages of double-negative (DN) thymocytes (Figure 1B,C) were similar in both genotypes, we found that the relative number of DP thymocytes was increased in Ptchflox/flox CD4Cre+/− mutant mice while the percentages of CD4 and CD8 SP thymocytes were decreased (Figure 1C). Even though the magnitude of these differences was small, they nevertheless reached statistical significance and were qualitatively in line with previous reports , , . This encouraged us to ask whether the deletion of Ptch would also affect peripheral T cells.
Thymocytes were isolated from Ptchflox/flox control or Ptchflox/flox CD4Cre+/− mutant mice, counted and stained for CD4, CD8, and CD44 to identify different developmental stages. (A) Mean number of total thymocytes ± SEM is shown for four mice of each genotype. (B) Percentages of CD4−CD8−CD44+ (DN stages 1 and 2) or CD4−CD8−CD44− (DN stages 3 and 4) thymocytes amongst total DN thymocytes are depicted. (C) Percentages of DN, DP and CD4 SP or CD8 SP cells amongst total thymocytes are shown. Panels B and C refer to the mean ± SEM of four mice of each genotype. Statistical analysis was performed by unpaired t-test (*: p<0.05). Differences were not statistically different unless otherwise indicated.
In our previous work we demonstrated that recombination of the Ptch locus and the resulting expression of the non-functional Ptchdel allele were almost complete in thymocytes of Ptchflox/flox CD4Cre+/− mice . Nonetheless, this did not lead to an upregulation of the two target genes Gli1 and Gli2 as one would have predicted for activated canonical Hh signaling . Therefore we performed the same analysis for peripheral T cells by isolating splenocytes from mice of both genotypes followed by qRT-PCR analysis. Surprisingly, we again found that disruption of Ptch was almost complete in mutant T cells and that this had no effect on Gli1 and Gli2 expression (Figure 2A). We also analyzed expression of Ptch2 to determine whether this highly homologous protein might compensate for the loss of Ptch. Importantly, we could not detect any Ptch2 mRNA in T cells of either genotype while Ptch2 was abundantly expressed at embryonic stage E10.5.
Splenic T cells were purified from Ptchflox/flox control or Ptchflox/flox CD4Cre+/− mutant mice and used to generate cDNA for qRT-PCR analysis. Alternatively, total splenocytes were isolated from mice of each genotype and stained for TCRβ, CD4, CD8, CD44 and CD69 to identify different peripheral T cell subpopulations. (A) Relative expression of wt Ptch transcripts derived from the Ptchflox allele, Ptchdel transcripts after Cre-mediated recombination of the Ptchflox allele, Gli1 and Gli2 transcripts as well as Ptch2 transcripts are depicted. As a positive control for Ptch2 expression, cDNA from wt mouse embryos at stage E10.5 was used for PCR amplification. Gene expression was normalized to HPRT1 and the transcriptional level of each gene in Ptchflox/flox control mice or E10.5 embryos, respectively, was set to 1.0. All panels show the mean ± SEM of five Ptchflox/flox and three Ptchflox/flox CD4Cre+/− mice; n.d.: not detectable. Measurement of all samples was performed in duplicates. (B) Mean number of total splenocytes ± SEM is shown for ten Ptchflox/flox and eight Ptchflox/flox CD4Cre+/− mice. (C) The percentages of T cells amongst all splenocytes and of CD4+ or CD8+ T cells amongst total splenic T cells is depicted. (D) T cells showing a recently activated (CD69+) or effector memory (CD44hi) phenotype were identified amongst the CD4+ and CD8+ splenic T cells. Panels C and D show the mean ± SEM of five Ptchflox/flox and seven Ptchflox/flox CD4Cre+/− mice. Statistical analysis was performed by unpaired t-test (*: p<0.05).
Next we studied the cellular composition of peripheral lymphoid organs. Size and cellularity of the spleen were unaltered in Ptchflox/flox CD4Cre+/− mutant mice and the same was true for the percentages of splenic T cells as well as of CD4+ and CD8+ cells amongst them (Figure 2B,C). Similar observations were made for lymph nodes and peripheral blood (data not shown). To unravel a potentially more subtle impact of the ablation of Ptch, we enumerated recently activated T cells based on CD69 surface expression as well as the CD44hi memory T cells. Nonetheless, the percentages of both populations were similar amongst the CD4+ or CD8+ T cells in Ptchflox/flox control and Ptchflox/flox CD4Cre+/− mutant mice irrespective of whether we analyzed spleen, lymph nodes or blood (Figure 2D and data not shown). We conclude that the deletion of Ptch in the T cell compartment does not impact the composition of peripheral T cells.
Ablation of Ptch does not Impact Polyclonal T Cell Activation
To explore the role of Ptch for T cell activation, we sorted splenic T lymphocytes and stimulated them either with anti-CD3/CD28 antibodies or Concanavalin A (ConA). Since Hh signaling was previously reported to be particularly relevant under suboptimal stimulation conditions, anti-CD3/CD28 and ConA were used at two different concentrations. T cell proliferation and IFNγ production were monitored over a 72 hours period by 3H-thymidine incorporation assay and ELISA, respectively. When we stimulated the T cells under optimal conditions (1.0 µg/ml anti-CD3/CD28 or 2.5 µg/ml ConA), proliferation of Ptchflox/flox control and Ptchflox/flox CD4Cre+/− cells was strong but similar at any time point (Figure 3A). When we used anti-CD3/CD28 or ConA at suboptimal concentrations (0.01 µg/ml and 0.5 µg/ml, respectively), proliferation was overall much weaker but ablation of Ptch had again no effect (Figure 3A). Unlike activated T cells, resting T lymphocytes from control and Ptch-deficient mice hardly proliferated at all (data not shown). IFNγ secretion increased over time under optimal stimulation conditions, while it was very low under suboptimal conditions. Nonetheless, there was no difference between both genotypes (Figure 3B). We conclude that T cell activation is unaffected by the absence of Ptch both under optimal and suboptimal stimulation conditions.
Total T cells were isolated from the spleens of Ptchflox/flox control or Ptchflox/flox CD4Cre+/− mutant mice and 105 cells per well were stimulated with different concentrations of ConA or anti-CD3/CD28 antibodies in a total volume of 200 µl medium. For detection of IFNγ, 50 µl medium were removed at each time point and used for analysis by ELISA. For measurement of proliferation, an equal volume of fresh medium containing 37 kBq 3H-thymidine was added to the same wells and incubated for another 16 hours. (A) Proliferation was assessed by scintillation counting. (B) Quantification of IFNγ levels was achieved by ELISA. Each panel shows the mean ± SEM of five individual experiments. Statistical analysis for each experimental condition was performed by unpaired t-test and no differences were found in any case.
Ptch has No Impact on the Cytolytic Capacity of CTLs
We also determined the role of Ptch for the effector function of CD8+ T cells by analyzing the cytolytic capacity of alloreactive CTLs (Figure 4A). Ptchflox/flox control and Ptchflox/flox CD4Cre+/− mutant mice (H2b) were repeatedly immunized with allogeneic splenocytes from C3H/HeN (H2k) mice. Subsequently, the splenocytes of the recipients were harvested, restimulated in vitro with splenocytes from C3H/HeN mice and subjected to a chromium release assay using Ltk− target cells (H2k). The specific lysis of these targets cells by mutant and control CTLs was similar (p = 0.216 by 2-way ANOVA), indicating that Ptch was not required for the cytolytic function of CTLs in vitro.
(A) Specific lysis of Ltk− target cells (H2k) by alloreactive CTLs derived from Ptchflox/flox control or Ptchflox/flox CD4Cre+/− mutant mice (H2b), which had been immunized with splenocytes from C3H/HeN mice (H2k). Means of specific lysis of triplicates of the Ltk− cells were determined for eight individual mice of both genotypes. The diagram shows the mean of specific lysis ± SEM for both genotypes at several effector to target (E:T) ratios. Statistical analysis was achieved by 2-way ANOVA (p = 0.216). (B) Abundance and FoxP3 expression of splenic TCRβ+CD4+CD25+GITR+FoxP3+ Treg cells. Treg cells in the spleen were enumerated by FACS analysis and their percentage amongst the CD4+ T cells is depicted as the mean ± SEM from three Ptchflox/flox and five Ptchflox/flox CD4Cre+/− mice (left panel). The levels of intracellular FoxP3 expression in Treg cells were quantified by FACS and the mean fluorescent intensity (MFI) is depicted as mean ± SEM for three Ptchflox/flox and four Ptchflox/flox CD4Cre+/− mice (right). Both parameters were statistically similar based on analysis by unpaired t-test (C) Suppressive capacity of Treg cells from Ptch-deficient and control mice. CD4+CD25+ Treg cells were cocultured with CD4+CD25− Th cells at ratios of 1∶1, 1∶5 and 1∶10. Polyclonal activation was achieved using anti-CD3/CD28 antibodies and IL-2 levels were assessed in the cell culture supernatants after 48 hours. All values are normalized to cultures of activated CD4+CD25− Th cells which served as a positive control. Resting CD4+CD25− Th cells and activated CD4+CD25+ Treg cells served as negative controls. The figure shows the mean ± SEM of three (Ptchflox/flox) and four (Ptchflox/flox CD4Cre+/−) independent experiments, respectively. Based on the analysis by unpaired t-test, the suppressive capacity of Treg cells from both genotypes was similar.
The Abundance and Suppressive Capacity of Treg Cells is Independent of Ptch
To determine the abundance of naturally occurring Treg cells in the spleen we performed a flow cytometric analysis. Approximately 8% of all CD4+ T cells in Ptchflox/flox control mice were CD25+GITR+FoxP3+ Treg cells and their frequency was similar in mutant Ptchflox/flox CD4Cre+/− mice (Figure 4B, left panel). Given the importance of the transcription factor FoxP3 for Treg cell function, we determined its expression level in TCRβ+CD4+CD25+GITR+FoxP3+ cells by flow cytometry. However, there was no difference in FoxP3 expression between both genotypes (Figure 4B, right panel). The most important criterion to assess the function of Treg cells is their capacity to suppress IL-2 secretion and proliferation of conventional CD4+ Th cells. Therefore, we magnetically purified CD4+CD25− Th cells from mice of both genotypes and activated them with anti-CD3/CD28 antibodies. These cells were then used as indicator cells in co-cultures with CD4+CD25+ Treg cells sorted either from Ptchflox/flox control or Ptchflox/flox CD4Cre+/− mice. As revealed on the basis of IL-2 levels in culture supernatants, Treg cells suppressed the function of conventional T cells in a dose-dependent manner. However, the suppressive capacity of Treg cells was independent of Ptch expression (Figure 4C).
Deletion of Ptch has No Impact on T Cell Apoptosis
Synthetic glucocorticoids such as dexamethasone (Dex) and DNA-damage caused by γ-irradiation are known to induce T cell apoptosis by activating the pro-apoptotic proteins Bim and Puma . To assess the role of Ptch in this process, we sorted T cells from the spleens of Ptchflox/flox control or Ptchflox/flox CD4Cre+/− mutant mice. Spontaneous cell death was indistinguishable between both genotypes. When T cells were γ-irradiated with a dose of 1 or 2 Gy and cultured for up to 4 days, we observed a dose- and time-dependent increase of cell death which was indistinguishable between both genotypes (Figure 5A). In another setting, we cultured T cells in the presence of either 2 nM or 6 nM Dex for up to 4 days. There was a dose- and time-dependent increase of apoptosis which was again unaltered in Ptch-deficient cells (Figure 5B). We also tested whether activated T cells may exhibit any difference concerning their sensitivity to apoptosis. Following activation by anti-CD3/CD28 antibodies for 24 hours the T cells were much more resistant to Dex-induced apoptosis as compared to naïve T cells, and not affected by the treatment unless the dose was considerably increased (Figure 5B,C). Nonetheless, activated T cells still underwent apoptosis in the presence of 10−6 M Dex, but there was no difference between cells isolated from Ptchflox/flox control or Ptchflox/flox CD4Cre+/− mice in this respect (Figure 5C). We conclude that ablation of Ptch does not impact apoptosis sensitivity, neither of resting nor activated peripheral T cells.
(A) Apoptosis induction by γ-irradiation was assessed by culturing 2 x 105 T cells following exposure to a dose of 1 or 2 Gy or without any manipulation. Cell viability was assessed every 24 hours by FACS analysis using 7-AAD. Results represent the mean ± SEM of three independent experiments. (B) Glucocorticoid-induced apoptosis was investigated by culturing 2 x 105 splenic T cells from Ptchflox/flox control or Ptchflox/flox CD4Cre+/− mutant mice in medium with or without 2 or 6 nM of water-soluble Dex for 4 days. Cell survival was determined as described above. Results represent the mean ± SEM of three independent experiments. (C) T cells were pre-activated with 1.5 µg/ml soluble anti-CD3 and anti-CD28 for 24 hours. Apoptosis was then induced by adding 1 µM of water-soluble Dex and cell viability was assessed up to four days after apoptosis induction similar as above. Results represent the mean ± SEM from three Ptchflox/flox or four Ptchflox/flox CD4Cre+/− animals. Based on the analysis by unpaired t-test, apoptosis was not different between both genotypes.
Adaptive Immune Responses do not Require Ptch Expression in T Lymphocytes
Since we had not observed any major difference in T cell function in vitro, we wondered whether Ptch deletion might only be relevant under more physiological conditions in vivo. To address this question, we initially analyzed a mouse model of graft-versus-host disease (GvHD), which depends on the function of both Th cells and CTLs. In humans, GvHD occurs after transplantation of a MHC mismatched bone marrow graft containing mature alloreactive T cells. In our experimental model, lethally irradiated Balb/c mice were transplanted with bone marrow and purified T cells from either Ptchflox/flox control or Ptchflox/flox CD4Cre+/− C57BL/6 mice. Upon encountering the allogeneic MHC molecules, the transferred T cells attack the host cells and induce a strong adaptive immune response dominated by Th1 cells. This leads to the occurrence of several typical disease symptoms, and eventually the mice succumb to death. Importantly, disease severity and mortality were similar in mice of both genotypes as confirmed by statistical analysis (Figure 6A,B). This indicates that Ptch in T cells does not affect any T cell effector functions required for the occurrence of GvHD.
GvHD was induced in irradiated Balb/c mice (8.5 Gy) by transferring 107 T cell-depleted syngeneic bone marrow cells plus 2×106 T cells from either Ptchflox/flox control or Ptchflox/flox CD4Cre+/− mutant C57BL/6 donor mice (n = 29 for each genotype). Control animals received T cell depleted bone marrow only (n = 13). Mice were monitored every other day for clinical symptoms (A) and survival (B). The figures show the combined data of five independent experiments. Statistical analysis of the disease courses was performed by Mann Whitney test; in the case of the survival curves the log-rank test was employed. In both cases, no statistical significant difference between both genotypes was found.
In another approach we studied allergic airway inflammation, which is an experimental model of human asthma and represents a prototypic Th2 immune response. Ptchflox/flox control and Ptchflox/flox CD4Cre+/− mice were repeatedly immunized with ovalbumin in adjuvant and subsequently challenged intranasally to induce an inflammatory response in the lung. Compared to control mice, intranasal ovalbumin application led to a strong infiltration of leukocytes into the lung (Figure 7A,C). The bronchoalveolar lavage fluid (BALF) was dominated by eosinophils but also contained CD4+ T cells, macrophages and neutrophils (Figure 7B). Nonetheless, neither the absolute numbers of the infiltrating cells nor their relative percentages were significantly different between both genotypes (Figure 7A–C). We also checked the titers of ovalbumin-specific antibody isotypes. The predominant one found in the serum was IgG1 with smaller amounts of IgG2a and IgE (Figure 7D), a finding which is typical for an allergic immune response induced in C57BL/6 mice. However, the antibody titers of all three isotypes were not significantly different between Ptchflox/flox control and Ptchflox/flox CD4Cre+/− mice. The proliferative response of splenic T cells restimulated with ovalbumin in vitro was increased in immunized mice but to a similar extent in both genotypes (Figure 7E). Thus, we did not find any indication that the allergic immune response in a model of asthma was influenced by the presence of Ptch in T cells.
Ptchflox/flox control and Ptchflox/flox CD4Cre+/− mutant C57BL/6 mice were sensitized against Ova by repeated intraperitoneal injection of antigen plus adjuvant. Control mice (Ptchflox/flox) received adjuvant without Ova. Antigen challenge was achieved by intranasal delivery of dissolved Ova for three consecutive days and analysis was performed after a two day resting phase. (A) Lungs were washed in situ and total cell counts in the broncheoalveolar lavage fluid (BALF) were determined using light microscopy. (B) Identification of different populations of lung-infiltrating cells within the BALF by using FACS. (C) Lung histology of mice 48 hours after the last challenge. A control lung obtained from a non-sensitized mouse challenged with Ova is shown along with lungs of Ptchflox/flox and Ptchflox/flox CD4Cre+/− mice which were both sensitized and challenged with antigen. No pathohistological signs of inflammation could be detected in control mice whereas a clear and massive cell influx was seen in sensitized and challenged mice. (D) Serum concentrations of Ova-specific IgG1, IgG2a and IgE immunoglobulins were quantified using ELISA and are depicted in the form of optical densities (OD). (E) Splenocytes were isolated and restimulated ex vivo with 10 µg/ml Ova for 72 hours and proliferation was assessed by 3H-thymidine incorporation assay. Results represent the mean ± SEM from nine non-sensitized control mice as well as thirteen Ptchflox/flox and fourteen Ptchflox/flox CD4Cre+/− animals, respectively. Statistical analysis of all parameters was performed by unpaired t-test and no differences were found in any case.
The Tumor Surveillance Capacity of the Immune System is Unaffected by Ptch Ablation in T Cells
Although we had not observed any effect of Ptch deletion on CTL and Treg cell function, we considered it possible that a potential role in these T cell subpopulations might only become evident in vivo. One function of the immune system in which both cell types are important is tumor surveillance. Whereas CTLs are one of the major effector cell types responsible for the lysis of neoplastic cells, Treg cells are known to be tumor promoting. To address this issue, we subcutaneously inoculated Ptchflox/flox control and Ptchflox/flox CD4Cre+/− mice with B16-F10 melanoma cells and monitored tumor incidence and size over a four weeks period. However, we did not detect any differences neither in tumor progression nor size (Figure 8A). We also immunized the mice prior to tumor inoculation by using inactivated tumor cells aiming at eliciting a protective anti-tumor response. This procedure indeed decreased tumor incidence, time of onset and tumor size, but to the same extent in both genotypes as revealed by statistical analysis (Figure 8B). We therefore conclude that Ptch in T cells is dispensable for proper tumor surveillance by the adaptive immune system.
C57BL/6 mice were inoculated with 104 B16-F10 melanoma cells into the right flank and tumor growth was monitored over a period of three weeks. The incidence of palpable tumors (left panel) and the mean tumor size ± SEM (right panel) are depicted for both experimental setups. (A) Results of tumor incidence and size are shown for eleven Ptchflox/flox control and nine Ptchflox/flox CD4Cre+/− mutant C57BL/6 mice in which tumorigenesis had been induced without additional manipulation. (B) To generate protective immunity, C57BL/6 mice were vaccinated with 106 irradiated B16-F10 cells together with adjuvant subcutaneously into the left flank. Ten days later the vaccinated mice were challenged with 104 viable B16-F10 cells subcutaneously into the right flank. Tumor incidence rate and mean tumor size ± SEM are shown for fourteen Ptchflox/flox and Ptchflox/flox CD4Cre+/− mice each. Statistical analysis of tumor incidence and size was performed by Mann Whitney test and not found to be different between both genotypes.
Stromal expression of the Hh receptor Ptch plays a critical role in pre-thymic T cell development , , yet it is unknown whether it also fulfills an intrinsic function in peripheral T cells. In fact, all major components of the Hh signaling pathway are expressed in T lymphocytes and, according to the current view, at least Hh and Gli2 are required for proper T cell function. Our current data support a role of the Hh receptor Ptch in intermediate and late thymocyte development but argue against an important function in peripheral T cells both in vitro and in vivo.
We employed a mouse model in which Ptch was specifically inactivated in T cells by Cre recombinase expressed under the control of the CD4 promoter, which becomes active at the DN3 stage of thymocyte development . Using this strategy we found that Ptch inactivation, despite being highly efficient, affected thymocyte development only moderately. This finding was distinct from our earlier data showing that T cell development was completely independent of T cell-intrinsic Ptch expression . The discrepancy could be explained by the different genetic backgrounds of the mouse strains used in both studies. Here we almost exclusively analyzed mice backcrossed to C57BL/6 for more than 10 generations, while we had previously used mice on a mixed Balb/c and C57BL/6 background.
The alterations in thymocyte development that we observed here were qualitatively similar to those reported to occur in response to activated Hh signaling , , . Importantly, however, our analyses did not reveal any impact of the deletion of Ptch on the number and phenotype of peripheral T cells. In vitro analysis demonstrated that functional characteristics of conventional T cells such as proliferation and cytokine production in response to polyclonal stimulation were nearly unaltered in Ptch-deficient T cells. Of note, the proliferation rate of polyclonally activated Ptch deficient T cells was slightly higher as compared to control cells, but this difference only emerged under highly unphysiological conditions and was insignificant at any time point. We were also unable to see differences when assessing the susceptibility of either resting or preactivated T cells to apoptosis induction. Functional analysis of CTL and CD4+CD25+FoxP3+ Treg cells in vitro did not reveal any impact of Ptch ablation on these cell types either. However, we cannot exclude that other lymphocyte populations such as induced Treg cells might be affected by the absence of Ptch.
Since more subtle effects in T lymphocytes might only become evident in vivo, we used three models of adaptive immune responses addressing different aspects of T cell function. Nevertheless, we were unable to identify an impact of Ptch ablation in any of these settings.
Surprisingly, there was no evidence of activated canonical Hh signaling when we analyzed target gene expression in T cells from Ptchflox/flox CD4Cre+/− mice. Both Gli1 and Gli2 levels were unchanged despite successful Ptch deletion. This is consistent with our previous data  and could be explained by the lack of primary cilia in cells of the hematopoietic lineage such as T cells . Primary cilia are microtubule-based organelles that protrude from the surface of most vertebrate cells and fulfill crucial roles in vertebrate development by providing hubs for the transduction of various developmental signaling pathways including Wnt, FGF, PDGF and also Hh . Although the interaction between Hh signaling and the primary cilium is currently not fully understood, it has recently become evident that the Hh pathway is strictly coupled to this cellular compartment . Therefore, the lack of primary cilia may prevent Ptch-mediated activation of Hh signaling in T cells. This hypothesis is indirectly supported by work showing that the deletion of Ptch in hematopoietic stem cells also failed to activate canonic Hh signaling . Alternatively, compensatory mechanisms might account for the canonical pathway not being activated by Ptch ablation. As a potential candidate mechanism, we investigated expression of the Ptch homolog Ptch2, which fulfills distinct roles from Ptch  but might still be able to compensate for its lack in selected cell types. However we were unable to detect Ptch2 transcripts both in Ptch deficient and control T cells. Yet the existence of other compensatory mechanisms still has to be elucidated.
Previous studies by other groups had pursued different approaches to investigate the role of Hh signaling in T cells. Initial work focused on the in vitro response of human and murine (C57Bl/6) T cells to exogenous Shh. It was reported that addition of Shh enhanced T cell activation and proliferation induced by optimal or suboptimal concentrations of anti-CD3 and anti-CD28 antibodies whereas addition of an anti-Hh antibody to these cultures reduced activation and proliferation , , . These changes were accompanied by an increased expression of the activation-dependent cell surface markers CD25 and CD69 and an enhanced secretion of cytokines such as IL-2 and IFNγ. Considering the current model of Hh signaling and our own findings, these results are difficult to explain. It is possible that addition of Shh to partially purified T cell populations activated these cells indirectly through other cell types present in the culture, or alternatively that Shh activated a non-canonical signaling pathway. It is also noteworthy that due to the artificial nature of in vitro experiments, the results may not reflect the physiological situation.
In another approach, Rowbotham and colleagues utilized transgenic mouse models on a C57Bl/6 background that either expressed the transcriptional activator (Gli2ΔN2) or repressor (Gli2ΔC2) form of Gli2 to study the effect of constitutive activation or repression of Hh signaling in T cells, respectively , . They found that activation of the Hh signaling pathway exerted a negative impact on TCR signal strength with implications for positive and negative selection in the thymus and the function of peripheral T cells. Although the data obtained in both mouse models were consistent, the results need to be carefully evaluated in view of the design of the employed experimental system. Both models relied on the overexpression of artificial forms of the transcription factor Gli2 and due to this constraint, the obtained data does not necessarily reflect the physiologic function of this protein. Another group focused on the role of Hh signaling in T cells by inactivating the signal transducer Smo at different time points during T cell development . They found that an early shutdown of Smo at the pro-T cell stage led to thymic atrophy, which was associated with a substantial decrease in thymocyte and peripheral T cell numbers. In contrast, a deletion of Smo in at a later stage of T cell development had no effect, neither on thymocyte numbers nor subtype distribution, suggesting that Hh signaling was essential for proliferation of early thymocytes while it becomes dispensable after pre-TCR expression. These findings are in line with the current model of Hh signaling as well as our own data. It is widely accepted that most vertebrate cells including stem cells possess primary cilia  while hematopoietic cells lose this compartment upon maturation. It is therefore conceivable that cells may also become refractory to Hh signaling once they are committed to the hematopoietic lineage. According to the findings of El Andaloussi et al. , the time window during which T cells lose responsiveness to Hh is the DN stage of thymocyte development. This suggests that canonical Hh signaling via Ptch is dispensable for all subsequent steps of T cell development as well as the function of peripheral T lymphocytes.
Collectively, our studies demonstrate that the Hh receptor Ptch is neither required for peripheral T cell function in vitro nor in vivo. We propose that this is either due to the lack of the primary cilium which is required for signal initiation in most cell types, or yet elusive compensatory mechanisms or a consequence of non-canonical Hh signaling. Therefore, it is unlikely that Ptch, but not necessarily Hh signaling itself, plays an essential role in peripheral T cell function and adaptive immunity.
We would like to thank Amina Bassibas, Julian Koch, Leslie Elsner and Ina Heß for expert technical assistance, Penelope Pelczar for her support in maintaining the Ptchflox/flox CD4Cre+/− mouse colony and Stefan Wolf, Susann Peter and Jaqueline Klie for excellent animal care.
Conceived and designed the experiments: KDM AU HH HMR. Performed the experiments: KDM AU RD JvdB. Analyzed the data: KDM AU RD JvdB HMR. Wrote the paper: KDM HH HMR.
- 1. Jiang J, Hui CC (2008) Hedgehog signaling in development and cancer. Dev Cell 15: 801–812.
- 2. Scales SJ, de Sauvage FJ (2009) Mechanisms of Hedgehog pathway activation in cancer and implications for therapy. Trends Pharmacol Sci 30: 303–312.
- 3. Chan VS, Chau SY, Tian L, Chen Y, Kwong SK, et al. (2006) Sonic hedgehog promotes CD4+ T lymphocyte proliferation and modulates the expression of a subset of CD28-targeted genes. Int Immunol 18: 1627–1636.
- 4. Lowrey JA, Stewart GA, Lindey S, Hoyne GF, Dallman MJ, et al. (2002) Sonic hedgehog promotes cell cycle progression in activated peripheral CD4(+) T lymphocytes. J Immunol 169: 1869–1875.
- 5. Outram SV, Varas A, Pepicelli CV, Crompton T (2000) Hedgehog signaling regulates differentiation from double-negative to double-positive thymocyte. Immunity 13: 187–197.
- 6. Shah DK, Hager-Theodorides AL, Outram SV, Ross SE, Varas A, et al. (2004) Reduced thymocyte development in sonic hedgehog knockout embryos. J Immunol 172: 2296–2306.
- 7. El Andaloussi A, Graves S, Meng F, Mandal M, Mashayekhi M, et al. (2006) Hedgehog signaling controls thymocyte progenitor homeostasis and differentiation in the thymus. Nat Immunol 7: 418–426.
- 8. Rowbotham NJ, Hager-Theodorides AL, Cebecauer M, Shah DK, Drakopoulou E, et al. (2007) Activation of the Hedgehog signaling pathway in T-lineage cells inhibits TCR repertoire selection in the thymus and peripheral T-cell activation. Blood 109: 3757–3766.
- 9. Hager-Theodorides AL, Furmanski AL, Ross SE, Outram SV, Rowbotham NJ, et al. (2009) The Gli3 transcription factor expressed in the thymus stroma controls thymocyte negative selection via Hedgehog-dependent and -independent mechanisms. J Immunol 183: 3023–3032.
- 10. Siggins SL, Nguyen NY, McCormack MP, Vasudevan S, Villani R, et al. (2009) The Hedgehog receptor Patched1 regulates myeloid and lymphoid progenitors by distinct cell-extrinsic mechanisms. Blood 114: 995–1004.
- 11. Uhmann A, Dittmann K, Nitzki F, Dressel R, Koleva M, et al. (2007) The Hedgehog receptor Patched controls lymphoid lineage commitment. Blood 110: 1814–1823.
- 12. Uhmann A, van den Brandt J, Dittmann K, Hess I, Dressel R, et al. (2011) T cell development critically depends on prethymic stromal patched expression. J Immunol 186: 3383–3391.
- 13. Stewart GA, Lowrey JA, Wakelin SJ, Fitch PM, Lindey S, et al. (2002) Sonic hedgehog signaling modulates activation of and cytokine production by human peripheral CD4+ T cells. J Immunol 169: 5451–5457.
- 14. Rowbotham NJ, Furmanski AL, Hager-Theodorides AL, Ross SE, Drakopoulou E, et al. (2008) Repression of hedgehog signal transduction in T-lineage cells increases TCR-induced activation and proliferation. Cell Cycle 7: 904–908.
- 15. Wolfer A, Bakker T, Wilson A, Nicolas M, Ioannidis V, et al. (2001) Inactivation of Notch 1 in immature thymocytes does not perturb CD4 or CD8T cell development. Nat Immunol 2: 235–241.
- 16. Wüst S, van den Brandt J, Tischner D, Kleiman A, Tuckermann JP, et al. (2008) Peripheral T cells are the therapeutic targets of glucocorticoids in experimental autoimmune encephalomyelitis. J Immunol 180: 8434–8443.
- 17. Tischner D, Theiss J, Karabinskaya A, van den Brandt J, Reichardt SD, et al. (2011) Acid Sphingomyelinase Is Required for Protection of Effector Memory T Cells against Glucocorticoid-Induced Cell Death. J Immunol 187: 4509–4516.
- 18. Sbiera S, Dexneit T, Reichardt SD, Michel KD, van den Brandt J, et al. (2011) Influence of short-term glucocorticoid therapy on regulatory T cells in vivo. PLoS ONE 6: e24345.
- 19. Dressel R, Elsner L, Quentin T, Walter L, Günther E (2000) Heat shock protein 70 is able to prevent heat shock-induced resistance of target cells to CTL. J Immunol 164: 2362–2371.
- 20. Voigt H, Schrama D, Eggert AO, Vetter CS, Müller-Blech K, et al. (2006) CD28-mediated costimulation impacts on the differentiation of DC vaccination-induced T cell responses. Clin Exp Immunol 143: 93–102.
- 21. Hwang PH, Yi HK, Kim DS, Nam SY, Kim JS, et al. (2001) Suppression of tumorigenicity and metastasis in B16F10 cells by PTEN/MMAC1/TEP1 gene. Cancer Lett 172: 83–91.
- 22. Drakopoulou E, Outram SV, Rowbotham NJ, Ross SE, Furmanski AL, et al. (2010) Non-redundant role for the transcription factor Gli1 at multiple stages of thymocyte development. Cell Cycle 9: 4144–4152.
- 23. Furmanski AL, Saldana JI, Rowbotham NJ, Ross SE, Crompton T (2012) Role of Hedgehog signalling at the transition from double-positive to single-positive thymocyte. Eur J Immunol 42: 489–499.
- 24. Rowbotham NJ, Hager-Theodorides AL, Furmanski AL, Crompton T (2007) A novel role for Hedgehog in T-cell receptor signaling: implications for development and immunity. Cell Cycle 6: 2138–2142.
- 25. Erlacher M, Michalak EM, Kelly PN, Labi V, Niederegger H, et al. (2005) BH3-only proteins Puma and Bim are rate-limiting for gamma-radiation- and glucocorticoid-induced apoptosis of lymphoid cells in vivo. Blood 106: 4131–4138.
- 26. Pazour GJ, Witman GB (2003) The vertebrate primary cilium is a sensory organelle. Curr Opin Cell Biol 15: 105–110.
- 27. Eggenschwiler JT, Anderson KV (2007) Cilia and developmental signaling. Annu Rev Cell Dev Biol 23: 345–373.
- 28. Goetz SC, Anderson KV (2010) The primary cilium: a signalling centre during vertebrate development. Nat Rev Genet 11: 331–344.
- 29. Rahnama F, Toftgard R, Zaphiropoulos PG (2004) Distinct roles of PTCH2 splice variants in Hedgehog signalling. Biochem J 378: 325–334.
- 30. Kiprilov EN, Awan A, Desprat R, Velho M, Clement CA, et al. (2008) Human embryonic stem cells in culture possess primary cilia with hedgehog signaling machinery. J Cell Biol 180: 897–904.